POPULATION FREQUENCY OF REPEAT EXPANSIONS INDICATES INCREASED DISEASE PREVALENCE ESTIMATES ACROSS DIFFERENT POPULATIONS.


Journal

medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986

Informations de publication

Date de publication:
06 Jul 2023
Historique:
pubmed: 18 7 2023
medline: 18 7 2023
entrez: 18 7 2023
Statut: epublish

Résumé

Repeat expansion disorders (REDs) are a devastating group of predominantly neurological diseases. Together they are common, affecting 1 in 3,000 people worldwide with population-specific differences. However, prevalence estimates of REDs are hampered by heterogeneous clinical presentation, variable geographic distributions, and technological limitations leading to under-ascertainment. Here, leveraging whole genome sequencing data from 82,176 individuals from different populations we found an overall carrier frequency of REDs of 1 in 340 individuals. Modelling disease prevalence using genetic data, age at onset and survival, we show that REDs are up to 3-fold more prevalent than currently reported figures. While some REDs are population-specific, e.g. Huntington's disease type 2, most REDs are represented in all broad genetic ancestries, including Africans and Asians, challenging the notion that some REDs are found only in European populations. These results have worldwide implications for local and global health communities in the diagnosis and management of REDs both at local and global levels.

Identifiants

pubmed: 37461547
doi: 10.1101/2023.07.03.23292162
pmc: PMC10350132
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS105781
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG075051
Pays : United States
Organisme : Medical Research Council
ID : MC_EX_MR/M009203/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S006753/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M009203/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_14089
Pays : United Kingdom

Auteurs

Kristina Ibañez (K)

William Harvey Research Institute, Queen Mary University of London, London, EC1M 6BQ, UK.

Bharati Jadhav (B)

Department of Genetics and Genomic Sciences and Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029.

Stefano Facchini (S)

Department of Neuromuscular Diseases, Institute of Neurology, University College London, London, UK.
IRCCS Mondino Foundation, Pavia, Italy.

Paras Garg (P)

Department of Genetics and Genomic Sciences and Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029.

Matteo Zanovello (M)

Department of Neuromuscular Diseases, Institute of Neurology, University College London, London, UK.

Alejandro Martin-Trujillo (A)

Department of Genetics and Genomic Sciences and Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029.

Scott J Gies (SJ)

Department of Genetics and Genomic Sciences and Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029.

Valentina Galassi Deforie (VG)

Department of Neuromuscular Diseases, Institute of Neurology, University College London, London, UK.

Delia Gagliardi (D)

William Harvey Research Institute, Queen Mary University of London, London, EC1M 6BQ, UK.
Department of Neuromuscular Diseases, Institute of Neurology, University College London, London, UK.

Davina Hensman (D)

St George's, University of London, London, SW17 0RE, UK.
Department of Neurodegenerative Disorders, Institute of Neurology, UCL, London, UK.

Loukas Moutsianas (L)

Genomics England Queen Mary University of London, UK.

Maryam Shoai (M)

Department of Neurodegenerative Disorders, Institute of Neurology, UCL, London, UK.

Mark J Caulfield (MJ)

William Harvey Research Institute, Queen Mary University of London, London, EC1M 6BQ, UK.

Andrea Cortese (A)

Department of Neuromuscular Diseases, Institute of Neurology, University College London, London, UK.

Valentina Escott-Price (V)

Department of Psychological Medicine and Clinical Neuroscience, School of Medicine, Cardiff University, UK.
Dementia Research Institute, Cardiff University, UK.

John Hardy (J)

Department of Neurodegenerative Disorders, Institute of Neurology, UCL, London, UK.

Henry Houlden (H)

Department of Neurodegenerative Disorders, Institute of Neurology, UCL, London, UK.
Neurogenetics Unit, National Hospital for Neurology and Neurosurgery, London, UK.

Andrew J Sharp (AJ)

Department of Genetics and Genomic Sciences and Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029.

Arianna Tucci (A)

William Harvey Research Institute, Queen Mary University of London, London, EC1M 6BQ, UK.
Department of Neuromuscular Diseases, Institute of Neurology, University College London, London, UK.

Classifications MeSH